Document Type
Patent
Publication Date
August 2012
Patent Number
8242101
Abstract
A method of inducing high anti-leukemia activity responsive to the combination of hydroxamic acid analogue histone deacetylase inhibitors and PKC412 against human acute leukemia characterized as expressing phosphorylated (p)FLT3 kinase by a novel flow cytometry-based assay.
Application Number
12/765,033
Recommended Citation
Bhalla, Kapil N., "Leukemia treatment method and composition" (2012). USF Patents. 346.
https://digitalcommons.usf.edu/usf_patents/346
Assignees
University of South Florida
Filing Date
04/22/2010
Primary/U.S. Class
514/183
COinS
